| 000 | 01682 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514032608.0 | ||
| 264 | 0 | _c20020524 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/00003246-200205001-00013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVoelkel, Norbert F | |
| 245 | 0 | 0 |
_aJanus face of vascular endothelial growth factor: the obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension. _h[electronic resource] |
| 260 |
_bCritical care medicine _cMay 2002 |
||
| 300 |
_aS251-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 |
_aEndothelial Growth Factors _xphysiology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xetiology |
| 650 | 0 | 4 |
_aLymphokines _xphysiology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Growth Factor _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Vascular Endothelial Growth Factor |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
| 650 | 0 | 4 | _aVascular Endothelial Growth Factors |
| 700 | 1 | _aCool, Carlyne | |
| 700 | 1 | _aTaraceviene-Stewart, Laima | |
| 700 | 1 | _aGeraci, Mark W | |
| 700 | 1 | _aYeager, Michael | |
| 700 | 1 | _aBull, Todd | |
| 700 | 1 | _aKasper, Michael | |
| 700 | 1 | _aTuder, Rubin M | |
| 773 | 0 |
_tCritical care medicine _gvol. 30 _gno. 5 Suppl _gp. S251-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-200205001-00013 _zAvailable from publisher's website |
| 999 |
_c11903088 _d11903088 |
||